Effects of EECP combined with aerobic exercise on cardiopulmonary function in patients with chronic heart failure

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300070572

Enrollment

Unknown

Registered

2023-04-17

Start date

2023-04-25

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure

Interventions

one:Conventional treatment and aerobic exercise

two:conventional treatment and enhanced external counterpulsation

three:conventional treatment\aerobic exercise and enhanced external counterpulsation

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) be diagnosed by "Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2018", ejection fraction = 50%, previous history of ischemic heart disease or myocardial infarction, and confirmed by cardiovascular doctors (clinical confirmed by auxiliary examinations such as ambulatory electrocardiogram and coronary angiography). (2) NYHA Class II; (3) Age= 60 years old; (4) Stable drug therapy for the past 30 days; (5) Voluntarily participate in this research project and agree to sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Congenital heart disease (2) Unstable angina (3) Severe valvular disease (4) Decompensated heart failure (5) Severe liver and kidney dysfunction; (6) Uncontrolled diabetes or hypertension (> 180/110mmHg) (7) Patients with acute and chronic infections and malignant tumors; (8) New stroke or myocardial infarction (9) Bone or neuromuscular abnormalities that cannot perform power car exercise (10) Deep vein thrombosis of the lower extremities, active thrombophlebitis (11) Moderate to severe pulmonary hypertension (mean pulmonary artery pressure> 50mmHg) (12) Aortic aneurysm, cerebral aneurysm (13) Arrhythmias that may interfere with the ECG gating function of EECP devices (14) Bleeding disorders or obvious bleeding tendency (15) There is a foci of infection in the counterpulsating limb (16) Moderate to severe cognitive impairment or dementia

Design outcomes

Primary

Measure	Time frame
peak oxygen uptake;ejection fraction;	—

Secondary

Measure	Time frame
CO2 ventilation equivalent slope;heart rate recovery;mental state;quality of life;	—

Countries

China

Contacts

Public ContactHe Jing

Tianjin Fourth Central Hospital

hejinggansu@163.com+86 13512041018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026